Science Explorer Interactive view Map
Company · Tokyo · Japan

Astellas Pharma (Japan)

In research, Astellas Pharma (Japan) stands highest in Medicine (#7,068 of 10,443 worldwide) and Health Sciences (#8,746 of 11,982 worldwide), 2022–2025.

astellas.com/en/index.htmlROR OpenAlex
World rank, 2022–2025
#12,525
of 28,054 · #11,424 all time
Rank in Japan
#325
of 1,070
Research works
1.5k
▼ 12% vs 2013–17
Citations
33k
22.4 per fractional work
Top-10% rate
15.5%
record average 16.5%
Open access
40%
world 28%

What is Astellas Pharma (Japan) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #7,068 of 10,443 17.2%77 #5909
Health SciencesDomain #8,746 of 11,982 16.7%80 #7815

Each strip is that field’s whole ranked pool, with the notch where Astellas Pharma (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.15× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.04× its world share, 34 worksBiochemistry, Geneti…Immunology and Microbiology: 4.48× its world share, 7 worksImmunology and Micro…Neuroscience: 2.39× its world share, 6 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 11.12× its world share, 6 worksPharmacology, Toxico…Chemistry: 1.34× its world share, 3 worksChemistryComputer Science: 0.26× its world share, 3 worksComputer ScienceEarth and Planetary Sciences: 0.09× its world share, 0 worksEarth and Planetary …Engineering: 0.26× its world share, 6 worksEngineeringEnvironmental Science: 0.16× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.32× its world share, 2 worksMaterials ScienceMathematics: 2.23× its world share, 4 worksMathematicsPhysics and Astronomy: 0.02× its world share, 0 worksPhysics and AstronomyDentistry: 0.14× its world share, 0 worksDentistryHealth Professions: 0.56× its world share, 2 worksHealth ProfessionsMedicine: 2.50× its world share, 77 worksMedicineNursing: 0.09× its world share, 0 worksNursingVeterinary: 1.10× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.02× its world share, 0 worksBusiness, Management…Decision Sciences: 0.33× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.75× its world share, 3 worksEconomics, Econometr…Psychology: 0.10× its world share, 0 worksPsychologySocial Sciences: 0.05× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 11.1×. Every wedge is a field page.

Who are the top researchers at Astellas Pharma (Japan)?

Ranked on the composite score, Tatsuya Maruyama, Mitsuyuki Matsumoto and Toshio Okazaki lead among researchers whose main affiliation is Astellas Pharma (Japan).

  1. 1 Tatsuya Maruyama Japan · #199,847 worldwide 100 citations · 24 works
  2. 2 Mitsuyuki Matsumoto Japan · #221,923 worldwide 70 citations · 29 works
  3. 3 Toshio Okazaki Japan · #773,397 worldwide 27 citations · 19 works
  4. 4 Hiroyuki Ito Japan · #832,442 worldwide 27 citations · 20 works
  5. 5 Kentaro Yamanaka Japan · #1,125,430 worldwide 33 citations · 19 works
  6. 6 Yusuke Yamaguchi Japan · #1,274,641 worldwide 27 citations · 26 works
  7. 7 Hiroki Shirai Japan · #1,558,951 worldwide 15 citations · 22 works
  8. 8 Keiji Miyata Japan · #1,573,976 worldwide 10 citations · 21 works
  9. 9 M. Ikeguchi Japan · #1,579,216 worldwide 0 citations · 27 works
All ranked researchers at Astellas Pharma (Japan)

Which keywords describe research at Astellas Pharma (Japan)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Immunotherapy, Heart Failure, Glycosylation, Tumor Microenvironment, Monoclonal Antibodies, Clinical Guidelines and Cancer Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation11▲ 3.4×34 topics
  2. Immunotherapy8▲ 7.0×11 topics
  3. Oxidative Stress7▲ 2.7×21 topics
  4. Cancer6▲ 3.0×24 topics
  5. Quality of Life6▲ 2.6×12 topics
  6. Cardiovascular Disease6▲ 3.4×13 topics
  7. Heart Failure6▲ 7.9×5 topics
  8. Chemotherapy5▲ 4.8×11 topics
  9. Cancer Therapy5▲ 5.6×9 topics
  10. Glycosylation5▲ 28×3 topics
  11. Tumor Microenvironment5▲ 7.2×7 topics
  12. Monoclonal Antibodies5▲ 33×3 topics
  13. Biomarkers4▲ 4.1×8 topics
  14. Clinical Guidelines4▲ 9.8×5 topics
  15. Therapeutic Antibodies4▲ 39×2 topics
  16. Cell Culture4▲ 23×2 topics
  17. Tumor Regression4▲ 23×2 topics
  18. Glycemic Control4▲ 16×4 topics
  19. Insulin Therapy4▲ 21×3 topics
  20. Type 2 Diabetes4▲ 11×3 topics
  21. Clinical Trials4▲ 3.7×10 topics
  22. Regenerative Medicine4▲ 9.7×3 topics
  23. Cancer Immunotherapy4▲ 15×2 topics
  24. Cardiovascular Risk4▲ 7.6×6 topics
  25. Lymphoma4▲ 15×3 topics
  26. Transcriptional Regulation4▲ 15×7 topics
  27. CAR T Cells4▲ 30×1 topic
  28. Chimeric Antigen Receptor4▲ 30×1 topic
  29. Cancer Treatment4▲ 9.5×5 topics
  30. Autoantibodies3▲ 9.1×7 topics
  31. Breast Cancer3▲ 8.9×6 topics
  32. Gene Therapy3▲ 11×5 topics
  33. Pharmacokinetics3▲ 8.0×4 topics
  34. Bayesian Methods3▲ 41×2 topics
  35. Cardiovascular Outcomes3▲ 37×1 topic
  36. Glucose Control3▲ 37×1 topic
  37. Biopharmaceuticals3▲ 37×3 topics
  38. Chronic Kidney Disease3▲ 8.1×4 topics
  39. Nuclear Receptors3▲ 21×5 topics
  40. Hormone Therapy3▲ 21×3 topics

Which research topics does Astellas Pharma (Japan) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Diabetes Treatment and Management, Statistical Methods in Clinical Trials and Monoclonal and Polyclonal Antibodies Research.

CAR-T cell therapy resea…4CAR-T cell therapy research: 4 fractional worksDiabetes Treatment and M…3Diabetes Treatment and Management: 3 fractional worksStatistical Methods in C…3Statistical Methods in Clinical Trials: 3 fractional worksMonoclonal and Polyclona…2Monoclonal and Polyclonal Antibodies Research: 2 fractional works3D Printing in Biomedical Research: 2 fractional worksDrug Solubulity and Delivery Systems: 2 fractional worksErythropoietin and Anemi…2Erythropoietin and Anemia Treatment: 2 fractional worksProtein purification and stability: 2 fractional worksViral Infectious Diseases and Gene Expression in Insects: 2 fractional worksImmune Cell Function and…2Immune Cell Function and Interaction: 2 fractional works
OncologyEndocrinology, Diabetes and MetabolismStatistics and ProbabilityRadiology, Nuclear Medicine and Imaging5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 4 works
  2. 2 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 3 works
  3. 3 Statistical Methods in Clinical Trials Statistics and Probability 3 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  5. 5 3D Printing in Biomedical Research Biomedical Engineering 2 works
  6. 6 Drug Solubulity and Delivery Systems Pharmaceutical Science 2 works
  7. 7 Erythropoietin and Anemia Treatment Hematology 2 works
  8. 8 Protein purification and stability Molecular Biology 2 works
  9. 9 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 2 works
  10. 10 Immune Cell Function and Interaction Immunology 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.1%not open59.9%

World: 28% of research is openly available.

with international co-authors19.4%domestic only80.6%

World: 19% is written across borders.

How has Astellas Pharma (Japan)'s research output changed?

Output in 2018–2022 was 12% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.